Board member and acting Chief Executive Officer
Daniel Spasic started his career in the pharmaceutical industry in 1993 by joining Pharmacia & Upjohn in Lund, Sweden. He served at the Medical Department in Sweden and Italy working with clinical development in the therapeutic areas of CNS and oncology. In 1996, he founded TFS Trial Form Support a clinical contract research organisation (CRO) with focus in the area of clinical trials. Under his guidance, TFS has become the largest non-listed European clinical CRO serving pharmaceutical/biotechnological, medical device and diagnostic companies in their clinical product development process. He is an active member of the Drug Information Association (DIA), SwedenBio and Medicon Valley Alliance. He is also a member of the Board of Medicon Valley Alliance (MVA) and a member in the Steering Group for the global MVA Life Science Ambassador Program. Medicon Valley Alliance is one of the strongest bioregions in Europe. He is a member of the external strategic committee at Alligator Bioscience AB in Lund, Sweden. Daniel did in 2010 receive the Swedish national award as "Man of The Year" by Ernst & Young and was awarded the title "Entrepreneur of The Year" in South Sweden by Founders Alliance. Daniel holds a technical degree in chemical engineering.